Immunotherapy with interleukin-2 after autologous bone marrow transplantation for hematologic malignancies

Prog Clin Biol Res. 1994:389:229-38.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Bone Marrow Transplantation*
  • Clinical Trials as Topic
  • Clinical Trials, Phase I as Topic
  • Combined Modality Therapy
  • Humans
  • Immunotherapy
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / therapeutic use*
  • Killer Cells, Lymphokine-Activated / immunology
  • Leukemia / therapy*
  • Lymphoma / therapy*
  • Transplantation, Autologous

Substances

  • Interleukin-2